Back to ROIV
STATE STREET CORP ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
12
Latest value
$629.8M
Q2 2026
Peak value
$629.8M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $154.2M |
| Q1 2024 | $180.8M |
| Q2 2024 | $194.9M |
| Q3 2024 | $225.7M |
| Q4 2024 | $246.1M |
| Q1 2025 | $190.3M |
| Q2 2025 | $222.8M |
| Q3 2025 | $282.9M |
| Q4 2025 | $376.7M |
| Q1 2026 | $448.4M |
| Q2 2026 | $629.8M |
| Q2 2026 | $629.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $629.8M | 17.80M | — | — |
| Q2 2026 | $629.8M | 17.80M | — | — |
| Q1 2026 | $448.4M | 16.19M | — | — |
| Q4 2025 | $376.7M | 17.36M | — | — |
| Q3 2025 | $282.9M | 18.70M | — | — |
| Q2 2025 | $222.8M | 19.77M | — | — |
| Q1 2025 | $190.3M | 18.86M | — | — |
| Q4 2024 | $246.1M | 20.80M | — | — |
| Q3 2024 | $225.7M | 19.56M | — | — |
| Q2 2024 | $194.9M | 18.44M | — | — |
| Q1 2024 | $180.8M | 17.15M | — | — |
| Q4 2023 | $154.2M | 13.73M | — | — |
Other funds holding ROIV
$1.2B
$1.2B
$857.7M
$841.4M
$758.4M